Advances in Management of Mitochondrial Myopathies
International Journal of Molecular Sciences · 05.06.2025 · 26 (11) · 5411
DOI: 10.3390/ijms26115411 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.06.2025. Verfasst von Athanasios Bangeas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of T…. Hauptthemen laut MEDLINE: Mitochondrial Myopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondria, the energy factories of human organisms, can be the cause of a variety of genetic disorders called mitochondrial myopathies. Mitochondrial diseases arise from genetic alterations in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) and can manifest with great heterogeneity, leading to multiorgan dysfunction. The purpose of this article is to concisely review the pathophysiology, genetics and main clinical features of mitochondrial myopathies, focusing mainly on the treatment and management of these disorders. Currently, a particular treatment for mitochondrial myopathies does not exist, while the available guidelines concerning management are based on experts’ opinions. The therapeutic options currently applied largely aim at symptom relief and amelioration of patients’ quality of life. The most commonly used regimens involve the administration of vitamins and cofactors, although hard evidence regarding their true benefit for patients is still lacking. Recent studies have demonstrated promising results for elamipretide; however, phase III clinical trials are still ongoing. Regarding patient management, a multidisciplinary approach with the collaboration of different specialties is required. Further clinical trials for the already applied treatment options, as well as on novel experimental therapies, are of utmost importance in order to improve patients’ outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.
- First Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Stilponos Kyriakidi 1, 54636 Thessaloniki, Greece.
- Neurology Department, St. Josef Hospital Bochum, Ruhr University Bochum, Gudrunstr. 56, 44791 Bochum, Germany.
- Department of Clinical Neurophysiology, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Stilponos Kyriakidi 1, 54636 Thessaloniki, Greece.
- Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.
ORCID-Profile: Vasiliki Poulidou, Ioannis Liampas, Chrysa Marogianni, Athina-Maria Aloizou, Markos Sgantzos, Dimitrios P Bogdanos, Efthimios Dardiotis
Zitieren
APA
Bangeas, A., Poulidou, V., Liampas, I., Marogianni, C., Aloizou, A. M., Tsouris, Z., Sgantzos, M., Arnaoutoglou, M., Bogdanos, D. P., Dardiotis, E., & Siokas, V. (2025). Advances in Management of Mitochondrial Myopathies. International Journal of Molecular Sciences, 26(11), 5411. https://doi.org/10.3390/ijms26115411
Vancouver
Bangeas A, Poulidou V, Liampas I, Marogianni C, Aloizou AM, Tsouris Z, et al. Advances in Management of Mitochondrial Myopathies. International Journal of Molecular Sciences. 2025;26(11):5411. doi:10.3390/ijms26115411
BibTeX
@article{Bangeas2025,
author = {Bangeas, Athanasios and Poulidou, Vasiliki and Liampas, Ioannis and Marogianni, Chrysa and Aloizou, Athina-Maria and Tsouris, Zisis and Sgantzos, Markos and Arnaoutoglou, Marianthi and Bogdanos, Dimitrios P and Dardiotis, Efthimios and Siokas, Vasileios},
title = {Advances in Management of Mitochondrial Myopathies},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {11},
pages = {5411},
doi = {10.3390/ijms26115411}
}
EUVIMED